Hosted on MSN
Alexander disease: FDA approves first drug that can target the root cause of the rare neurological disease
The US Food and Drug Administration (FDA) recently approved the first drug for Alexander disease, a rare and progressive neurological disorder. Alexander disease is marked by symptoms like seizures, ...
The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, ...
Brigham and Women's nurses postponed the Oct. 14 strike to vote on a final offer. See the pay, insurance, and staffing terms, and what patients face. New CPSC recalls cover Amazon baby bath seats and ...
A New Drug Application is expected to be submitted to the FDA in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to zilganersen for the ...
For the first time, patients living with a rare neurological disease have a new treatment option — and the FDA’s decision could mark a major moment for the community. Here’s what to know about the ...
The Food and Drug Administration recently approved the first drug to treat Alexander disease, a rare, progressive and often fatal neurological disorder that can affect motor, cognitive and autonomic ...
A Prescription Drug User Fee Act target date of September 22, 2026 has been set for the application. The Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA ...
Add Yahoo as a preferred source to see more of our stories on Google. (NewsNation) — The FDA approved the first drug to treat Alexander disease, the administration announced Thursday in a news release ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The FDA approved Zanvastro (zilganersen) from Ionis as the first disease-modifying therapy for Alexander disease, a rare GFAP-related brain disorder, for adults and children. The intrathecal antisense ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results